1. Association of COVID-19 with impaired endothelial glycocalyx, coronary flow and longitudinal strain four months after infection. (4th February 2022) Authors: Ikonomidis, I; Katogiannis, K; Mitrakou, A; Kountouri, A; Thymis, J; Korakas, E; Varlamos, C; Andreadou, I; Tsoumani, M; Bamias, A; Kazakou, P; Grigoropoulou, S; Kavatha, D; Dimopoulos, MA; Lambadiari, V Journal: European heart journal Issue: Volume 23(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial efficiency four months after infection. (4th February 2022) Authors: Katogiannis, K; Ikonomidis, I; Thymis, J; Mitrakou, A; Kountouri, A; Stamoulis, K; Korakas, E; Varlamos, C; Andreadou, I; Tsoumani, M; Bamias, A; Thomas, K; Antoniadou, A; Dimopoulos, MA; Lambadiari, V Journal: European heart journal Issue: Volume 23(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP881 Neoadjuvant chemotherapy for newly diagnosed ovarian cancer: a single center experience. (1st November 2019) Authors: Kaparelou, M; Zakopoulou, R; Tsiara, A; Kyriazoglou, A; Liontos, M; Tsironis, G; Koutsoukos, K; Zagouri, F; Vlachos, D; Thomakos, N; Haidopoulos, D; Rodolakis, A; Dimopoulos, MA; Bamias, A Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 POLLUX TRIAL. (5th April 2022) Authors: Dimopoulos, MA; Oriol, A; Nahi, H; San-Miguel, J; Bahlis, NJ; Usmani, SZ; Rabin, N; Orlowski, RZ; Suzuki, K; Plesner, T; Yoon, SS; Ben Yehuda, D; Richardson, PG; Goldschmidt, H; Reece, D; Ahmadi, T; Qin, X; Garvin Mayo, W; Gai, X; Carey, J Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY. (5th April 2022) Authors: Terpos, E; Ntanasis-Stathopoulos, I; Kastritis, E; Hatjiharissi, E; Katodritou, E; Eleutherakis-Papaiakovou, E; Verrou, E; Gavriatopoulou, M; Leonidakis, A; Delimpasi, S; Malandrakis, P; Kyrtsonis, M-C; Papaioannou, M; Symeonidis, A; Dimopoulos, MA Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗